These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7497472)

  • 1. Gemfibrozil-induced peroxisome proliferation and hepatomegaly in male F344 rats.
    Sausen PJ; Teets VJ; Voss KS; Miller RT; Cattley RC
    Cancer Lett; 1995 Nov; 97(2):263-8. PubMed ID: 7497472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
    Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
    Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS; Cattley RC; Conway JG; Popp JA
    Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes.
    Corton JC; Bocos C; Moreno ES; Merritt A; Cattley RC; Gustafsson JA
    Biochimie; 1997; 79(2-3):151-62. PubMed ID: 9209713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hepatic ornithine decarboxylase by hypolipidemic drugs with hepatic peroxisome proliferative activity.
    Izumi K; Reddy JK; Oyasu R
    Carcinogenesis; 1981; 2(7):623-7. PubMed ID: 7273341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
    Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
    Marsman DS; Goldsworthy TL; Popp JA
    Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.
    Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA
    Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication.
    Wada N; Marsman DS; Popp JA
    Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method for determining whether the number of hepatocytes in rat liver is increased after treatment with the peroxisome proliferator gemfibrozil.
    Carthew P; Maronpot RR; Foley JF; Edwards RE; Nolan BM
    J Appl Toxicol; 1997; 17(1):47-51. PubMed ID: 9048227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate.
    Tharappel JC; Cunningham ML; Spear BT; Glauert HP
    Toxicol Sci; 2001 Jul; 62(1):20-7. PubMed ID: 11399789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
    Moya-Camarena SY; Van den Heuvel JP; Belury MA
    Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate.
    Cattley RC; Kato M; Popp JA; Teets VJ; Voss KS
    Carcinogenesis; 1994 Aug; 15(8):1763-6. PubMed ID: 8055661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorgenicity.
    Hofstra AH; King LM; Walker RM
    Fundam Appl Toxicol; 1995 Sep; 27(2):277-86. PubMed ID: 8529824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK; Azarnoff DL; Sirtori CR
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
    Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
    Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC; Popp JA
    Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.